Cystotech Invest ApS: Financial statements 2024
CVR: 43238191
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Cystotech Invest ApS (CVR 43238191) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -14,849 and a net result of DKK -14,849 compared with DKK -21,520 the year before. Equity in the 2024 report amounted to DKK 6,628,549. The solvency ratio was 99.9%.
- Gross Profit
- DKK -14,849
- Profit/Loss
- DKK -14,849
- Equity
- DKK 6,628,549
- Total Assets
- DKK 6,635,299
- Employees
- 0
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Cystotech Invest ApS has published its annual report for 2023. Gross profit came to DKK -21,520, and the net result was DKK -21,520.
About Cystotech Invest ApS
Cystotech Invest ApS is a Danish company of the type Anpartsselskab based in Silkeborg, founded in 2022. The company is registered under the industry Investering for egen regning. The management consists of Morten Petersen. The board consists of Bo Wase, Flemming Frandsen, Morten Petersen and Ole Niels Jakob Jensen. The company's owners include WAP HOLDING ApS, MORTEN PETERSEN ApS and POUL CARSTENSEN HOLDING ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -24,281 and a net result of DKK -24,281 compared with DKK -14,849 the year before. Equity in the 2025 report amounted to DKK 8,804,268.
